Environmental, Social And Governance Report

Overview

The report presents JW Therapeutics' 2024 ESG performance across governance and environmental management. It reports 8,209.00 MWh of total energy consumption and 19,291.00 m3 of water consumption. It also tracks a 40% reduction target for Scope 1 and Scope 2 GHG emissions intensity by 2025 from a 2021 base, alongside 25% female representation on the Board.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services